Risk of cancer in patients with ankylosing spondylitis: a nationwide cohort study in Taiwan

References

• Gabriel SE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther 2009;11:229.
   PubMed Web of Science ®Google Scholar
• Braun J, Sieper J. Ankylosing spondylitis. Lancet 2007;369:1379–90.
   PubMed Web of Science ®Google Scholar
• Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A. Ankylosing spondylitis: an overview. Ann Rheum Dis 2002;61:iii8–18.
   PubMed Web of Science ®Google Scholar
• Wikipedia. Autoimmune disease. (http://en.wikipedia.org/wiki/Autoimmune_disease). Accessed 30 July 2020.
   Google Scholar
• Landgren AM, Landgren O, Gridley G, Dores GM, Linet MS, Morton LM. Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans. Cancer 2011;117:1163–71.
   PubMed Web of Science ®Google Scholar
• Zhu W, He X, Cheng K, Zhang L, Chen D, Wang X, et al. Ankylosing spondylitis: etiology, pathogenesis, and treatments. Bone Res 2019;7:1–16.
   PubMed Web of Science ®Google Scholar
• Hemminki K, Liu X, Ji J, Sundquist J, Sundquist K. Autoimmune disease and subsequent digestive tract cancer by histology. Ann Oncol 2012;23:927–33.
   PubMed Web of Science ®Google Scholar
• Nannini C, Cantini F, Niccoli L, Cassarà E, Salvarani C, Olivieri I, et al. Single-center series and systematic review of randomized controlled trials of malignancies in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis receiving anti-tumor necrosis factor alpha therapy: is there a need for more comprehensive screening procedures? Arthritis Rheum 2009;61:801–12.
   PubMed Web of Science ®Google Scholar
• Franks AL, Slansky JE. Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer. Anticancer Res 2012;32:1119–36.
   PubMed Web of Science ®Google Scholar
• Kuo CF, Luo SF, Yu KH, Chou IJ, Tseng WY, Chang HC, et al. Cancer risk among patients with systemic sclerosis: a nationwide population study in Taiwan. Scand J Rheumatol 2012;41:44–9.
   PubMed Web of Science ®Google Scholar
• Liang JA, Sun LM, Yeh JJ, Lin WY, Chang SN, Sung HC, et al. Malignancies associated with systemic lupus erythematosus in Taiwan: a nationwide population-based cohort study. Rheumatol Int 2012;32:773–8.
   PubMed Web of Science ®Google Scholar
• Olsson J, Drott JB, Laurantzon L, Laurantzon O, Bergh A, Elgh F. Chronic prostatic infection and inflammation by Propionibacterium acnes in a rat prostate infection model. PloS One 2012;7:e51434.
   PubMed Web of Science ®Google Scholar
• Baecklund E, Iliadou A, Askling J, Ekbom A, Backlin C, Granath F, et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 2006;54:692–701.
   PubMed Web of Science ®Google Scholar
• Wick RR, Atkinson MJ, Nekolla EA. Incidence of leukaemia and other malignant diseases following injections of the short-lived alpha-emitter 224Ra into man. Radiat Environ Biophys 2009;48:287–94.
   PubMed Web of Science ®Google Scholar
• Nekolla EA, Walsh L, Spiess H. Incidence of malignant diseases in humans injected with radium-224. Radiat Res 2010;174:377–86.
   PubMed Web of Science ®Google Scholar
• Askling J, Klareskog L, Blomqvist P, Fored M, Feltelius N. Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study. Ann Rheum Dis 2006;65:1184–7.
   PubMed Web of Science ®Google Scholar
• Feltelius N, Ekbom A, Blomqvist P. Cancer incidence among patients with ankylosing spondylitis in Sweden 1965–95: a population based cohort study. Ann Rheum Dis 2003;62:1185–8.
   PubMed Web of Science ®Google Scholar
• Shibata A, Zhao S, Makuch R, Wentworth J, Veith J, Wallis W. Lymphoma risk in ankylosing spondylitis patients is greater than that observed in the general population. Ann Rheum Dis 2004;63:98.
   PubMed Web of Science ®Google Scholar
• Hellgren K, Dreyer L, Arkema EV, Glintborg B, Jacobsson LT, Kristensen LE, et al. Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers. Ann Rheum Dis 2017;76:105–11.
   PubMed Web of Science ®Google Scholar
• Van Der Heijde D, Zack D, Wajdula J, Sridharan S, Koenig AS. Rates of serious infections, opportunistic infections, inflammatory bowel disease, and malignancies in subjects receiving etanercept vs. controls from clinical trials in ankylosing spondylitis: a pooled analysis. Scand J Rheumatol 2014;43:49–53.
   PubMed Web of Science ®Google Scholar
• Haynes K, Beukelman T, Curtis JR, Newcomb C, Herrinton LJ, Graham DJ, et al. Tumor necrosis factor α inhibitor therapy and cancer risk in chronic immune-mediated diseases. Arthritis Rheum 2013;65:48–58.
   PubMed Web of Science ®Google Scholar
• Carmona L, Abasolo L, Descalzo MA, Pérez-Zafrilla B, Sellas A, de Abajo F, et al. Cancer in patients with rheumatic diseases exposed to TNF antagonists. Semin Arthritis Rheum 2011;41:71–80.
   PubMed Web of Science ®Google Scholar
• Sahai H, Khurshid A. Confidence intervals for the mean of a Poisson distribution: a review. Biom J 1993;35:857–67.
   Web of Science ®Google Scholar
• Buchbinder R, Barber M, Heuzenroeder L, Wluka AE, Giles G, Hall S, et al. Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum 2008;59:794–9.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Michaud K. Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study. Arthritis Rheum 2007;56:2886–95.
   PubMed Web of Science ®Google Scholar
• Mercer LK, Askling J, Raaschou P, Dixon WG, Dreyer L, Hetland ML, et al. Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers. Ann Rheum Dis 2017;76:386–91.
   PubMed Web of Science ®Google Scholar
• Raaschou P, Simard JF, Holmqvist M, Askling J. ARTIS Study Group. Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden. BMJ 2013;346:f1939.
   PubMed Web of Science ®Google Scholar
• Lakomek HJ, Plomann M, Specker C, Schwochau M. Ankylosing spondylitis: an autoimmune disease? Ann Rheum Dis 1991;50:776–81.
   PubMed Web of Science ®Google Scholar
• Sun LM, Muo CH, Liang JA, Chang SN, Sung FC, Kao CH. Increased risk of cancer for patients with ankylosing spondylitis: a nationwide population-based retrospective cohort study. Scand J Rheumatol 2014;43:301–6.
   PubMed Web of Science ®Google Scholar
• Wick RR, Nekolla EA, Gaubitz M, Schulte TL. Increased risk of myeloid leukaemia in patients with ankylosing spondylitis following treatment with radium-224. Rheumatol 2008;47:855–9.
   PubMed Web of Science ®Google Scholar
• Weiss HA, Darby SC, Fearn T, Doll R. Leukemia mortality after X-ray treatment for ankylosing spondylitis. Radiat Res 1995;142:1–11.
   PubMed Web of Science ®Google Scholar
• Dubreuil M, Peloquin C, Zhang Y, Choi HK, Inman RD, Neogi T. Validity of ankylosing spondylitis diagnoses in the health improvement network. Pharmacoepidemiol Drug Saf 2016;25:399–404.
   PubMed Web of Science ®Google Scholar